US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD

35.50

-3.4500-8.86%

Post-market: 36.110.6100+1.72%16:26 EDT

Volume:1.20M

Turnover:43.97M

Market Cap:2.53B

PE:-11.40

High:39.19

Open:39.19

Low:35.42

Close:38.95

52wk High:94.90

52wk Low:20.04

Shares:71.31M

Float Shares:54.64M

Volume Ratio:0.92

T/O Rate:2.20%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.1128

EPS(LYR):-2.3852

ROE:-20.21%

ROA:-14.95%

PB:1.87

PE(LYR):-14.88

Loading ...

Overview Company News Filings

Press Release: Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results

Advancing Oral GLP‑1 and Amylin Pipeline Supports GPCR Buy Rating with Maintained $70 Price Target

Structure Therapeutics Chief Commercial Officer John Joseph Berrios Files Initial Beneficial Ownership Statement

Piper Sandler Sticks to Their Buy Rating for Structure Therapeutics, Inc. Sponsored ADR (GPCR)

Structure Therapeutics Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Structure Therapeutics Q2 Net Loss Widens on Higher R&D Costs

Structure Therapeutics Inc. Q2 Net Income USD -106.159 Million

THOMSON REUTERS

Structure Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance

Structure Therapeutics CSO Lin Xichen Disposes of USD 401,255.43 in Common Shares

Race to Launch Weight-loss Pills Heats up as Smaller Players Advance

Trump’s FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?

Structure Therapeutics shareholders elect directors at annual meeting

Why Structure Therapeutics (GPCR) Is Up 13.7% After Phase 2b Obesity Data Hit Nature Medicine And ADA

Simply Wall St.

XtalPi Biopharma GPCR Pact Tests AI Drug Discovery And Revenue Potential

Simply Wall St.

Nxera Pharma Joins OpenFold AI Consortium to Boost GPCR Drug Discovery

XtalPi Strikes US$400 Million GPCR Drug Discovery Pact with Global Biopharma Partner

XTALPI Forges Strategic AI Drug Discovery Alliance Valued Over $400M with Global Pharma Leader for Oral GPCR Therapy

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)

How Phase 2b Oral GLP-1 Data and Phase 3 Plans Will Impact Structure Therapeutics (GPCR) Investors

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/GPCR/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GPCR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GPCR\",,,,,undefined,":{"symbol":"GPCR","market":"US","secType":"STK","nameCN":"STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD","latestPrice":35.5,"timestamp":1789588800000,"preClose":38.95,"halted":0,"volume":1204635,"hourTrading":{"tag":"盘后","latestPrice":36.11,"preClose":35.5,"latestTime":"16:26 EDT","volume":20919,"amount":742772.2927349999,"timestamp":1789590390681,"change":0.61,"changeRate":0.017183,"amplitude":0.017183},"delay":0,"changeRate":-0.08857509627727862,"floatShares":54641899,"shares":71309857,"eps":-3.1128,"marketStatus":"Post-Mkt","change":-3.45,"latestTime":"09-16 16:30:45 EDT","open":39.19,"high":39.19,"low":35.42,"amount":43967678,"amplitude":0.096791,"askPrice":36.9,"askSize":100,"bidPrice":35.05,"bidSize":65,"shortable":3,"etf":0,"ttmEps":-3.1128,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":4,"adr":0,"adrRate":3,"listingDate":1675400400000,"exchange":"NASDAQ","adjPreClose":38.95,"preHourTrading":{"tag":"盘前","latestPrice":38.95,"preClose":38.95,"latestTime":"08:35 EDT","volume":322,"amount":12527.11859,"timestamp":1789562104628,"change":0,"changeRate":0,"amplitude":0.073684},"postHourTrading":{"tag":"盘后","latestPrice":36.11,"preClose":35.5,"latestTime":"16:26 EDT","volume":20919,"amount":742772.2927349999,"timestamp":1789590390681,"change":0.61,"changeRate":0.017183,"amplitude":0.017183},"volumeRatio":0.916876,"impliedVol":0.8254,"impliedVolPercentile":0.6175},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GPCR\",,,,,undefined,":{"symbol":"GPCR","floatShares":54641899,"roa":"-14.95%","roe":"-20.21%","lyrEps":-2.385222,"volumeRatio":0.916876,"shares":71309857,"dividePrice":0,"high":39.19,"amplitude":0.096791,"preClose":38.95,"low":35.42,"week52Low":20.04,"pbRate":"1.87","week52High":94.9,"institutionHeld":0,"latestPrice":35.5,"committee":-0.212121,"eps":-3.1128,"divideRate":0,"volume":1204635,"delay":0,"ttmEps":-3.1128,"open":39.19,"prevYearClose":69.55,"prevWeekClose":38.66,"prevMonthClose":45.91,"prevQuarterClose":53.67,"fiveDayClose":41.23,"twentyDayClose":53.53,"sixtyDayClose":45.51},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GPCR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"GPCR","fiscalQuarterEnding":"2026/06","expectedEps":-0.39,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2026-05-07","symbol":"GPCR","fiscalQuarterEnding":"2026/03","expectedEps":-0.39,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.35},{"market":"US","date":"2026-02-26","symbol":"GPCR","fiscalQuarterEnding":"2025/12","expectedEps":-0.35,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2025-11-06","symbol":"GPCR","fiscalQuarterEnding":"2025/09","expectedEps":-0.36,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.37},{"market":"US","date":"2025-08-06","symbol":"GPCR","fiscalQuarterEnding":"2025/06","expectedEps":-0.28,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.36}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GPCR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GPCR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3529,"buy":0.5882,"hold":0.0588,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5882,"analysts":17,"updateTime":1777348800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GPCR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GPCR","date":"2026-09-15","current":-11.404523,"percent":0.767574,"low":-50.180001,"twenty":-24.168154,"median":-19.660066,"eighty":-10.743891,"high":-5.211405,"avg":-19.35414,"sd":8.1942,"marketCap":2741150903},"quantilePoints":[{"date":"2023-02-03","current":-25.001825,"twenty":-43.272389,"median":-43.272389,"eighty":-32.310051,"marketCap":951294422},{"date":"2023-02-10","current":-22.116999,"twenty":-35.964163,"median":-23.496907,"eighty":-22.21316,"marketCap":841529681},{"date":"2023-02-17","current":-21.285207,"twenty":-24.521021,"median":-22.645883,"eighty":-21.915061,"marketCap":809880847},{"date":"2023-02-24","current":-23.36709,"twenty":-23.715192,"median":-22.645883,"eighty":-21.847749,"marketCap":889094402},{"date":"2023-03-03","current":-25.530709,"twenty":-24.422936,"median":-22.718004,"eighty":-21.972757,"marketCap":971417957},{"date":"2023-03-10","current":-22.636267,"twenty":-24.85566,"median":-22.790125,"eighty":-22.063149,"marketCap":861287334},{"date":"2023-03-17","current":-22.232392,"twenty":-24.422936,"median":-22.70358,"eighty":-22.09392,"marketCap":845920270},{"date":"2023-03-24","current":-21.876596,"twenty":-23.762311,"median":-22.568955,"eighty":-21.891982,"marketCap":832382619},{"date":"2023-03-31","current":-16.960589,"twenty":-23.565181,"median":-22.314128,"eighty":-21.634271,"marketCap":870434396},{"date":"2023-04-06","current":-17.823234,"twenty":-23.376706,"median":-22.232392,"eighty":-21.285207,"marketCap":914706175},{"date":"2023-04-14","current":-17.473898,"twenty":-23.36709,"median":-22.116999,"eighty":-18.643102,"marketCap":896777933},{"date":"2023-04-21","current":-17.210114,"twenty":-23.194,"median":-22.059302,"eighty":-17.623613,"marketCap":883240282},{"date":"2023-04-28","current":-17.815518,"twenty":-23.078607,"median":-21.876596,"eighty":-17.586227,"marketCap":914310203},{"date":"2023-05-05","current":-17.709107,"twenty":-22.982446,"median":-21.689083,"eighty":-17.623613,"marketCap":908849077},{"date":"2023-05-12","current":-17.00755,"twenty":-22.790125,"median":-21.491953,"eighty":-17.586227,"marketCap":956079400},{"date":"2023-05-19","current":-15.32957,"twenty":-22.780509,"median":-20.818827,"eighty":-17.473898,"marketCap":861751761},{"date":"2023-05-26","current":-19.808636,"twenty":-22.761276,"median":-19.808636,"eighty":-17.466769,"marketCap":1113542462},{"date":"2023-06-02","current":-21.830342,"twenty":-22.668962,"median":-20.674586,"eighty":-17.472472,"marketCap":1227192672},{"date":"2023-06-09","current":-23.110075,"twenty":-22.668962,"median":-21.38858,"eighty":-17.563702,"marketCap":1299132872},{"date":"2023-06-16","current":-21.061141,"twenty":-22.668962,"median":-21.491953,"eighty":-17.586212,"marketCap":1183952020},{"date":"2023-06-23","current":-21.782692,"twenty":-22.640113,"median":-21.568882,"eighty":-17.608538,"marketCap":1224514048},{"date":"2023-06-30","current":-27.561913,"twenty":-22.772816,"median":-21.571672,"eighty":-17.623492,"marketCap":1549392931},{"date":"2023-07-07","current":-24.451072,"twenty":-23.059375,"median":-21.612515,"eighty":-17.625039,"marketCap":1374517018},{"date":"2023-07-14","current":-21.428724,"twenty":-23.103781,"median":-21.707815,"eighty":-17.644282,"marketCap":1204615694},{"date":"2023-07-21","current":-23.069233,"twenty":-23.103781,"median":-21.780436,"eighty":-17.700571,"marketCap":1296836908},{"date":"2023-07-28","current":-23.552536,"twenty":-23.333385,"median":-21.782692,"eighty":-17.727736,"marketCap":1324005814},{"date":"2023-08-04","current":-21.592094,"twenty":-23.51737,"median":-21.782692,"eighty":-17.804907,"marketCap":1213799550},{"date":"2023-08-11","current":-19.978813,"twenty":-23.374783,"median":-21.781564,"eighty":-17.817061,"marketCap":1123108978},{"date":"2023-08-18","current":-16.072919,"twenty":-23.333385,"median":-21.735043,"eighty":-17.644282,"marketCap":1053531639},{"date":"2023-08-25","current":-16.66259,"twenty":-23.197654,"median":-21.646551,"eighty":-17.586168,"marketCap":1092182818},{"date":"2023-09-01","current":-16.458249,"twenty":-23.185384,"median":-21.592094,"eighty":-17.468195,"marketCap":1078788845},{"date":"2023-09-08","current":-16.680105,"twenty":-23.150918,"median":-21.568882,"eighty":-17.319402,"marketCap":1093330873},{"date":"2023-09-15","current":-18.326514,"twenty":-23.110075,"median":-21.460338,"eighty":-17.211393,"marketCap":1201248026},{"date":"2023-09-22","current":-19.937893,"twenty":-23.078607,"median":-21.067948,"eighty":-17.309925,"marketCap":1306869070},{"date":"2023-09-29","current":-21.876218,"twenty":-23.069233,"median":-21.012104,"eighty":-17.319402,"marketCap":1433920470},{"date":"2023-10-06","current":-37.165618,"twenty":-23.194,"median":-21.285207,"eighty":-17.395476,"marketCap":2436094784},{"date":"2023-10-13","current":-44.162453,"twenty":-23.552536,"median":-21.525005,"eighty":-17.459473,"marketCap":2894716299},{"date":"2023-10-20","current":-45.222784,"twenty":-23.852048,"median":-21.571672,"eighty":-17.466769,"marketCap":2964217822},{"date":"2023-10-27","current":-47.275909,"twenty":-23.892891,"median":-21.592094,"eighty":-17.469621,"marketCap":3098794020},{"date":"2023-11-03","current":-48.538851,"twenty":-24.328544,"median":-21.646551,"eighty":-17.490333,"marketCap":3181576088},{"date":"2023-11-10","current":-38.273225,"twenty":-24.864943,"median":-21.735043,"eighty":-17.514986,"marketCap":2508695101},{"date":"2023-11-17","current":-27.570058,"twenty":-25.04304,"median":-21.781564,"eighty":-17.543453,"marketCap":2122673903},{"date":"2023-11-24","current":-32.691508,"twenty":-27.365869,"median":-21.782692,"eighty":-17.586168,"marketCap":2516984612},{"date":"2023-12-01","current":-35.337541,"twenty":-28.3175,"median":-21.830342,"eighty":-17.593664,"marketCap":2720707940},{"date":"2023-12-08","current":-37.983573,"twenty":-33.138225,"median":-21.904522,"eighty":-17.623452,"marketCap":2924431267},{"date":"2023-12-15","current":-37.177707,"twenty":-34.105722,"median":-22.049686,"eighty":-17.625039,"marketCap":2862386033},{"date":"2023-12-22","current":-20.939825,"twenty":-34.105722,"median":-22.001606,"eighty":-17.644282,"marketCap":1612198995},{"date":"2023-12-29","current":-23.446258,"twenty":-34.065552,"median":-22.068918,"eighty":-17.684898,"marketCap":1805174329},{"date":"2024-01-05","current":-26.187472,"twenty":-34.000259,"median":-22.102574,"eighty":-17.702705,"marketCap":2016225834},{"date":"2024-01-12","current":-28.789086,"twenty":-33.67371,"median":-22.232392,"eighty":-17.746366,"marketCap":2216529345},{"date":"2024-01-19","current":-27.710368,"twenty":-33.290514,"median":-22.259189,"eighty":-17.804907,"marketCap":2133476670},{"date":"2024-01-26","current":-26.745867,"twenty":-33.138225,"median":-22.283013,"eighty":-17.817061,"marketCap":2059217807},{"date":"2024-02-02","current":-28.598724,"twenty":-32.691508,"median":-22.44298,"eighty":-17.823234,"marketCap":2201872991},{"date":"2024-02-09","current":-29.823387,"twenty":-32.667396,"median":-22.576119,"eighty":-17.835432,"marketCap":2296162205},{"date":"2024-02-16","current":-28.427399,"twenty":-32.293017,"median":-22.636267,"eighty":-17.890184,"marketCap":2188682272},{"date":"2024-02-23","current":-26.035182,"twenty":-31.181303,"median":-22.647193,"eighty":-17.91403,"marketCap":2004500750},{"date":"2024-03-01","current":-25.743294,"twenty":-31.092467,"median":-22.775115,"eighty":-17.959972,"marketCap":1982027673},{"date":"2024-03-08","current":-22.849791,"twenty":-30.933832,"median":-22.849791,"eighty":-18.031985,"marketCap":1759251085},{"date":"2024-03-15","current":-18.291889,"twenty":-29.823387,"median":-22.775115,"eighty":-18.031985,"marketCap":1639319082},{"date":"2024-03-22","current":-22.815466,"twenty":-29.601298,"median":-22.761276,"eighty":-18.070517,"marketCap":2044722039},{"date":"2024-03-28","current":-22.311113,"twenty":-29.398245,"median":-22.645883,"eighty":-18.070517,"marketCap":1999521939},{"date":"2024-04-05","current":-20.434088,"twenty":-29.301795,"median":-22.601624,"eighty":-18.089549,"marketCap":1831303011},{"date":"2024-04-12","current":-20.928042,"twenty":-29.107626,"median":-22.568955,"eighty":-18.098906,"marketCap":1875571150},{"date":"2024-04-19","current":-18.81184,"twenty":-29.061939,"median":-22.455039,"eighty":-18.224405,"marketCap":1685917123},{"date":"2024-04-26","current":-20.267704,"twenty":-28.863962,"median":-22.311113,"eighty":-18.256547,"marketCap":1816391638},{"date":"2024-05-03","current":-20.281918,"twenty":-28.794162,"median":-22.289169,"eighty":-18.270537,"marketCap":1817665530},{"date":"2024-05-10","current":-20.105056,"twenty":-28.789086,"median":-22.270856,"eighty":-18.288305,"marketCap":1801815151},{"date":"2024-05-17","current":-17.123915,"twenty":-28.636796,"median":-22.232392,"eighty":-18.098906,"marketCap":1672681180},{"date":"2024-05-24","current":-18.288418,"twenty":-28.476893,"median":-22.116999,"eighty":-18.062811,"marketCap":1786430959},{"date":"2024-05-31","current":-16.11295,"twenty":-28.435013,"median":-22.068918,"eighty":-17.902107,"marketCap":1573929112},{"date":"2024-06-07","current":-26.55105,"twenty":-28.381712,"median":-22.102574,"eighty":-17.902107,"marketCap":2593533072},{"date":"2024-06-14","current":-24.646705,"twenty":-28.337752,"median":-22.198735,"eighty":-17.932407,"marketCap":2407514791},{"date":"2024-06-21","current":-22.312809,"twenty":-28.3175,"median":-22.24579,"eighty":-17.974375,"marketCap":2179537500},{"date":"2024-06-28","current":-18.680713,"twenty":-28.3175,"median":-22.24579,"eighty":-18.00318,"marketCap":1824750754},{"date":"2024-07-05","current":-17.874111,"twenty":-28.267548,"median":-22.198735,"eighty":-17.932407,"marketCap":1745961056},{"date":"2024-07-12","current":-20.408464,"twenty":-28.068249,"median":-22.08815,"eighty":-17.932407,"marketCap":1993519219},{"date":"2024-07-15","current":-20.943017,"twenty":-28.006064,"median":-22.078534,"eighty":-17.941595,"marketCap":2045734877},{"date":"2024-08-02","current":-17.387286,"twenty":-27.943879,"median":-22.068918,"eighty":-17.908069,"marketCap":1698407510},{"date":"2024-08-09","current":-16.461364,"twenty":-27.802578,"median":-21.942986,"eighty":-17.823234,"marketCap":1607962532},{"date":"2024-08-16","current":-20.792004,"twenty":-27.780694,"median":-21.876596,"eighty":-17.821691,"marketCap":2088244945},{"date":"2024-08-23","current":-22.295452,"twenty":-27.74971,"median":-21.929398,"eighty":-17.823234,"marketCap":2239243758},{"date":"2024-08-30","current":-21.822777,"twenty":-27.716713,"median":-21.953525,"eighty":-17.863936,"marketCap":2191770646},{"date":"2024-09-06","current":-21.851252,"twenty":-27.691332,"median":-21.926349,"eighty":-17.874111,"marketCap":2194630472},{"date":"2024-09-13","current":-22.944669,"twenty":-27.671026,"median":-21.901472,"eighty":-17.880178,"marketCap":2304447790},{"date":"2024-09-20","current":-22.067657,"twenty":-27.608415,"median":-21.926349,"eighty":-17.902107,"marketCap":2216365150},{"date":"2024-09-27","current":-23.650834,"twenty":-27.565171,"median":-22.001606,"eighty":-17.941595,"marketCap":2375371475},{"date":"2024-10-04","current":-24.083644,"twenty":-27.536769,"median":-22.068918,"eighty":-18.000093,"marketCap":2418840830},{"date":"2024-10-11","current":-22.130301,"twenty":-27.481934,"median":-22.12365,"eighty":-18.029927,"marketCap":2222656767},{"date":"2024-10-18","current":-22.563112,"twenty":-27.163394,"median":-22.116999,"eighty":-18.055104,"marketCap":2266126122},{"date":"2024-10-25","current":-21.333018,"twenty":-26.967956,"median":-22.11226,"eighty":-18.070517,"marketCap":2142581639},{"date":"2024-10-31","current":-21.560813,"twenty":-26.932422,"median":-22.097835,"eighty":-18.080033,"marketCap":2165460247},{"date":"2024-11-08","current":-21.839862,"twenty":-26.875803,"median":-22.107521,"eighty":-18.096607,"marketCap":2193486542},{"date":"2024-11-15","current":-19.500107,"twenty":-26.820843,"median":-22.068288,"eighty":-18.16223,"marketCap":2155736838},{"date":"2024-11-22","current":-15.573182,"twenty":-26.740791,"median":-22.039183,"eighty":-18.047398,"marketCap":1721615252},{"date":"2024-11-29","current":-17.170432,"twenty":-26.702879,"median":-21.932448,"eighty":-17.923218,"marketCap":1898191276},{"date":"2024-12-06","current":-16.181125,"twenty":-26.575564,"median":-21.883856,"eighty":-17.833409,"marketCap":1788823393},{"date":"2024-12-13","current":-16.424567,"twenty":-26.524021,"median":-21.851252,"eighty":-17.817061,"marketCap":1815735909},{"date":"2024-12-20","current":-15.523314,"twenty":-26.386717,"median":-21.835102,"eighty":-17.715324,"marketCap":1716102339},{"date":"2024-12-27","current":-15.30059,"twenty":-26.269962,"median":-21.822777,"eighty":-17.687076,"marketCap":1691480250},{"date":"2025-01-03","current":-14.601342,"twenty":-26.20397,"median":-21.78933,"eighty":-17.625803,"marketCap":1614178343},{"date":"2025-01-10","current":-14.005686,"twenty":-26.17605,"median":-21.782692,"eighty":-17.604018,"marketCap":1548328570},{"date":"2025-01-17","current":-13.974608,"twenty":-26.160821,"median":-21.780436,"eighty":-17.514986,"marketCap":1544892930},{"date":"2025-01-24","current":-14.482211,"twenty":-26.10752,"median":-21.737354,"eighty":-17.469621,"marketCap":1601008389},{"date":"2025-01-31","current":-15.7046,"twenty":-26.035182,"median":-21.700984,"eighty":-17.381485,"marketCap":1736143575},{"date":"2025-02-07","current":-15.549212,"twenty":-26.032644,"median":-21.680405,"eighty":-17.295679,"marketCap":1718965373},{"date":"2025-02-14","current":-12.622728,"twenty":-25.9819,"median":-21.605123,"eighty":-17.234446,"marketCap":1395442576},{"date":"2025-02-21","current":-12.115125,"twenty":-25.903236,"median":-21.581883,"eighty":-17.21037,"marketCap":1339327118},{"date":"2025-02-28","current":-11.819887,"twenty":-25.84482,"median":-21.567582,"eighty":-17.171628,"marketCap":1306688535},{"date":"2025-03-07","current":-11.01217,"twenty":-25.735679,"median":-21.559435,"eighty":-17.124089,"marketCap":1349277189},{"date":"2025-03-14","current":-9.547313,"twenty":-25.689992,"median":-21.491953,"eighty":-17.045645,"marketCap":1169794078},{"date":"2025-03-21","current":-10.235281,"twenty":-25.609403,"median":-21.417887,"eighty":-16.960589,"marketCap":1254088063},{"date":"2025-03-28","current":-9.33203,"twenty":-25.527539,"median":-21.321628,"eighty":-16.93886,"marketCap":1143416369},{"date":"2025-04-04","current":-7.64253,"twenty":-25.480594,"median":-21.202701,"eighty":-16.831205,"marketCap":936408691},{"date":"2025-04-11","current":-7.043483,"twenty":-25.340669,"median":-21.061141,"eighty":-16.666093,"marketCap":863009847},{"date":"2025-04-17","current":-8.672143,"twenty":-25.329214,"median":-21.042579,"eighty":-16.563339,"marketCap":1062562954},{"date":"2025-04-25","current":-11.068331,"twenty":-25.25285,"median":-20.951128,"eighty":-16.426861,"marketCap":1356158331},{"date":"2025-05-02","current":-12.790591,"twenty":-25.171712,"median":-20.933479,"eighty":-16.305436,"marketCap":1567180008},{"date":"2025-05-09","current":-12.551909,"twenty":-25.070517,"median":-20.891345,"eighty":-16.181125,"marketCap":1537935156},{"date":"2025-05-16","current":-9.774326,"twenty":-25.068859,"median":-20.829252,"eighty":-16.056814,"marketCap":1400885752},{"date":"2025-05-23","current":-9.895696,"twenty":-25.0453,"median":-20.693431,"eighty":-15.839386,"marketCap":1418280862},{"date":"2025-05-30","current":-9.000467,"twenty":-25.01052,"median":-20.672234,"eighty":-15.745511,"marketCap":1289973912},{"date":"2025-06-06","current":-8.619091,"twenty":-25.001825,"median":-20.550917,"eighty":-15.544032,"marketCap":1235314001},{"date":"2025-06-13","current":-8.920177,"twenty":-24.996225,"median":-20.487391,"eighty":-15.387426,"marketCap":1278466562},{"date":"2025-06-20","current":-8.679308,"twenty":-24.952868,"median":-20.449033,"eighty":-14.973238,"marketCap":1243944513},{"date":"2025-06-27","current":-8.462526,"twenty":-24.918331,"median":-20.434088,"eighty":-14.66039,"marketCap":1212874668},{"date":"2025-07-03","current":-8.175491,"twenty":-24.875783,"median":-20.408464,"eighty":-14.607558,"marketCap":1171735893},{"date":"2025-07-11","current":-7.587369,"twenty":-24.818526,"median":-20.385744,"eighty":-14.451133,"marketCap":1087444556},{"date":"2025-07-18","current":-7.840282,"twenty":-24.807686,"median":-20.281918,"eighty":-14.123781,"marketCap":1123692707},{"date":"2025-07-25","current":-7.334457,"twenty":-24.781668,"median":-20.180483,"eighty":-13.987039,"marketCap":1051196404},{"date":"2025-08-01","current":-7.145777,"twenty":-24.722332,"median":-20.085721,"eighty":-13.108576,"marketCap":1024154132},{"date":"2025-08-08","current":-5.211405,"twenty":-24.651853,"median":-19.971704,"eighty":-12.812535,"marketCap":932580977},{"date":"2025-08-15","current":-5.964179,"twenty":-24.61951,"median":-19.937893,"eighty":-12.626872,"marketCap":1067289809},{"date":"2025-08-22","current":-6.234546,"twenty":-24.540145,"median":-19.829477,"eighty":-12.490132,"marketCap":1115672078},{"date":"2025-08-29","current":-6.160517,"twenty":-24.4698,"median":-19.66456,"eighty":-12.119485,"marketCap":1102424552},{"date":"2025-09-05","current":-6.360074,"twenty":-24.389808,"median":-19.576169,"eighty":-11.77845,"marketCap":1138135274},{"date":"2025-09-12","current":-6.720564,"twenty":-24.139365,"median":-19.456275,"eighty":-11.057099,"marketCap":1202644966},{"date":"2025-09-19","current":-7.47695,"twenty":-24.11098,"median":-19.134734,"eighty":-10.896967,"marketCap":1338000122},{"date":"2025-09-26","current":-8.043434,"twenty":-24.072254,"median":-19.014985,"eighty":-10.567565,"marketCap":1439372495},{"date":"2025-10-03","current":-8.568076,"twenty":-24.020356,"median":-18.941828,"eighty":-10.325716,"marketCap":1533257136},{"date":"2025-10-10","current":-9.833009,"twenty":-23.986828,"median":-18.81071,"eighty":-10.186609,"marketCap":1759617036},{"date":"2025-10-17","current":-8.87063,"twenty":-23.947347,"median":-18.74276,"eighty":-9.917033,"marketCap":1587399198},{"date":"2025-10-24","current":-8.548764,"twenty":-23.914099,"median":-18.661907,"eighty":-9.852324,"marketCap":1529801259},{"date":"2025-10-31","current":-10.370526,"twenty":-23.886602,"median":-18.351918,"eighty":-9.836476,"marketCap":1855805594},{"date":"2025-11-07","current":-10.772858,"twenty":-23.868757,"median":-18.327399,"eighty":-9.850579,"marketCap":1927803018},{"date":"2025-11-14","current":-10.08006,"twenty":-23.852048,"median":-18.288418,"eighty":-9.817863,"marketCap":2123717400},{"date":"2025-11-21","current":-9.889979,"twenty":-23.841601,"median":-18.256152,"eighty":-9.836476,"marketCap":2083670157},{"date":"2025-11-28","current":-10.313341,"twenty":-23.799814,"median":-18.097181,"eighty":-9.841018,"marketCap":2172866288},{"date":"2025-12-05","current":-9.460856,"twenty":-23.776121,"median":-18.070517,"eighty":-9.814076,"marketCap":1993260474},{"date":"2025-12-12","current":-19.422835,"twenty":-23.650834,"median":-18.082412,"eighty":-9.833009,"marketCap":4092100041},{"date":"2025-12-19","current":-17.985707,"twenty":-23.62393,"median":-18.070517,"eighty":-9.841018,"marketCap":3789318618},{"date":"2025-12-26","current":-22.869735,"twenty":-23.621272,"median":-18.100056,"eighty":-9.848479,"marketCap":4818310220},{"date":"2026-01-02","current":-22.823793,"twenty":-23.615623,"median":-18.255492,"eighty":-9.851048,"marketCap":4808630734},{"date":"2026-01-09","current":-21.980412,"twenty":-23.576442,"median":-18.281194,"eighty":-9.851517,"marketCap":4630943013},{"date":"2026-01-16","current":-27.900487,"twenty":-23.621936,"median":-18.326514,"eighty":-9.853937,"marketCap":5878214018},{"date":"2026-01-23","current":-30.148409,"twenty":-23.790337,"median":-18.349084,"eighty":-9.86147,"marketCap":6351817477},{"date":"2026-01-30","current":-28.599475,"twenty":-23.883185,"median":-18.63625,"eighty":-9.874048,"marketCap":6025480495},{"date":"2026-02-06","current":-24.024872,"twenty":-24.012922,"median":-18.680713,"eighty":-9.881446,"marketCap":5061680173},{"date":"2026-02-13","current":-23.64092,"twenty":-24.104146,"median":-18.735704,"eighty":-9.886523,"marketCap":4980787319},{"date":"2026-02-20","current":-22.141212,"twenty":-24.072254,"median":-18.787312,"eighty":-9.891122,"marketCap":4664821216},{"date":"2026-02-27","current":-21.248606,"twenty":-24.026331,"median":-18.905431,"eighty":-9.903769,"marketCap":4476762617},{"date":"2026-03-06","current":-29.951815,"twenty":-24.389808,"median":-18.958825,"eighty":-9.939515,"marketCap":4229256176},{"date":"2026-03-13","current":-27.383083,"twenty":-24.63457,"median":-19.091174,"eighty":-9.953915,"marketCap":3866546098},{"date":"2026-03-20","current":-25.316057,"twenty":-24.813106,"median":-19.247915,"eighty":-9.965451,"marketCap":3574677833},{"date":"2026-03-27","current":-23.178791,"twenty":-24.786548,"median":-19.412443,"eighty":-10.00684,"marketCap":3272891714},{"date":"2026-04-02","current":-25.170562,"twenty":-24.791427,"median":-19.500107,"eighty":-10.024679,"marketCap":3554133708},{"date":"2026-04-10","current":-27.664038,"twenty":-24.924896,"median":-19.588971,"eighty":-10.070397,"marketCap":3906217513},{"date":"2026-04-17","current":-26.841241,"twenty":-25.001825,"median":-19.762743,"eighty":-10.08006,"marketCap":3790036942},{"date":"2026-04-24","current":-23.59019,"twenty":-25.001825,"median":-19.852578,"eighty":-10.16646,"marketCap":3330982000},{"date":"2026-05-01","current":-20.863024,"twenty":-25.001825,"median":-19.937893,"eighty":-10.183801,"marketCap":2945900742},{"date":"2026-05-08","current":-19.705365,"twenty":-24.994825,"median":-19.961493,"eighty":-10.197841,"marketCap":2782437010},{"date":"2026-05-15","current":-16.62279,"twenty":-24.933886,"median":-19.910742,"eighty":-10.230435,"marketCap":2831476129},{"date":"2026-05-22","current":-16.184689,"twenty":-24.924896,"median":-19.829477,"eighty":-10.235281,"marketCap":2756851382},{"date":"2026-05-29","current":-20.218762,"twenty":-24.916142,"median":-19.78569,"eighty":-10.28472,"marketCap":2854929621},{"date":"2026-06-05","current":-19.660066,"twenty":-24.837612,"median":-19.705365,"eighty":-10.310089,"marketCap":2776040603},{"date":"2026-06-12","current":-21.794185,"twenty":-24.818526,"median":-19.734054,"eighty":-10.313341,"marketCap":3077382440},{"date":"2026-06-18","current":-18.776621,"twenty":-24.802267,"median":-19.684963,"eighty":-10.332349,"marketCap":3198353220},{"date":"2026-06-26","current":-20.13271,"twenty":-24.776789,"median":-19.66456,"eighty":-10.358393,"marketCap":3429345397},{"date":"2026-07-02","current":-21.747499,"twenty":-24.722332,"median":-19.762743,"eighty":-10.368595,"marketCap":3704403773},{"date":"2026-07-10","current":-23.007619,"twenty":-24.651853,"median":-19.829477,"eighty":-10.39842,"marketCap":3919048812},{"date":"2026-07-17","current":-19.206397,"twenty":-24.633491,"median":-19.854838,"eighty":-10.468301,"marketCap":3271559971},{"date":"2026-07-24","current":-21.196718,"twenty":-24.602614,"median":-19.924318,"eighty":-10.512193,"marketCap":3610585412},{"date":"2026-07-31","current":-20.641765,"twenty":-24.584569,"median":-19.948142,"eighty":-10.52082,"marketCap":3516056306},{"date":"2026-08-07","current":-21.956128,"twenty":-24.559431,"median":-19.978813,"eighty":-10.545017,"marketCap":3739941031},{"date":"2026-08-14","current":-18.156488,"twenty":-24.476043,"median":-19.948142,"eighty":-10.550775,"marketCap":3900649177},{"date":"2026-08-21","current":-16.769027,"twenty":-24.436431,"median":-19.854838,"eighty":-10.567565,"marketCap":3602573975},{"date":"2026-08-28","current":-16.33752,"twenty":-24.340741,"median":-19.804817,"eighty":-10.589873,"marketCap":3509871161},{"date":"2026-09-04","current":-15.713495,"twenty":-24.190229,"median":-19.757177,"eighty":-10.628294,"marketCap":3375808630},{"date":"2026-09-11","current":-13.127772,"twenty":-24.182202,"median":-19.66456,"eighty":-10.724579,"marketCap":2820304844},{"date":"2026-09-15","current":-12.759331,"twenty":-24.168154,"median":-19.660066,"eighty":-10.743891,"marketCap":2741150903}],"updateTime":1789590645812},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GPCR\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658411956","title":"Press Release: Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658411956","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658411956?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:01","pubTimestamp":1786392060,"startTime":"0","endTime":"0","summary":"-- Septerna's Phase 1 clinical trial of SEP-479, a potent, selective. oral small molecule PTH1R agonist for the treatment of. serum calcium and endogenous serum PTH) in healthy volunteers.-- Based on pharmacokinetic data from the ongoing Phase 1 clinical. trial, the observed elimination half-life of SEP-479 is. approximately three to four days, which the Company anticipates. will support once-daily dosing. To fully characterize steady-state. pharmacokinetics, dosing for the MAD cohorts will be extended to. 14 days. As a result, Septerna expects to report Phase 1 data from. both the SAD and MAD cohorts in the first quarter of 2027.-- During the quarter, the Company presented the first detailed. preclinical characterization of SEP-479 in an oral presentation at. ENDO 2026, highlighting data supporting its potential as a. -- As reported in March 2026, SEP-631, an oral small molecule MRGPRX2","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4022","LU2065732104.USD","R","BK4599","SEPN","PRGS","BK4232","BK4097","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657626045","title":"Advancing Oral GLP‑1 and Amylin Pipeline Supports GPCR Buy Rating with Maintained $70 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2657626045","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657626045?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:28","pubTimestamp":1786134487,"startTime":"0","endTime":"0","summary":"Analyst Ananda Ghosh from H.C. Wainwright maintained a Buy rating on Structure Therapeutics, Inc. Sponsored ADR and keeping the price target at $70...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/advancing-oral-glp1-and-amylin-pipeline-supports-gpcr-buy-rating-with-maintained-70-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/advancing-oral-glp1-and-amylin-pipeline-supports-gpcr-buy-rating-with-maintained-70-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLP","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657626825","title":"Structure Therapeutics Chief Commercial Officer John Joseph Berrios Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2657626825","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657626825?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:07","pubTimestamp":1786133263,"startTime":"0","endTime":"0","summary":"Structure Therapeutics Chief Commercial Officer John Joseph Berrios files initial beneficial ownership statementStructure Therapeutics filed a Form 3 for Chief Commercial Officer John Joseph Berrios, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL21XJ5k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4007","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657566647","title":"Piper Sandler Sticks to Their Buy Rating for Structure Therapeutics, Inc. Sponsored ADR (GPCR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657566647","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657566647?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:27","pubTimestamp":1786116471,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Structure Therapeutics, Inc. Sponsored ADR today and set a price target of $93.00. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-their-buy-rating-for-structure-therapeutics-inc-sponsored-adr-gpcr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-their-buy-rating-for-structure-therapeutics-inc-sponsored-adr-gpcr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CVY","ARMH","DIVL","SAPH","DINT","APIE","GPCR","AADR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657666456","title":"Structure Therapeutics Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657666456","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657666456?lang=en_us&edition=fundamental","pubTime":"2026-08-07 07:41","pubTimestamp":1786059693,"startTime":"0","endTime":"0","summary":"Structure Therapeutics Inc. reports results for the quarter ended June 30 - Earnings SummaryStructure Therapeutics Inc.GPCR.OQreported a quarterly adjusted loss of 49 cents per share for the quarter e","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N4433PM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GPCR","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657663595","title":"Structure Therapeutics Q2 Net Loss Widens on Higher R&D Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2657663595","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657663595?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:45","pubTimestamp":1786049151,"startTime":"0","endTime":"0","summary":"Structure Therapeutics Q2 net loss widens on higher R&D costsOverviewBiopharmaceutical firm's Q2 net loss widened as operating expenses rose on clinical trial costsCompany dosed first patients in Phas","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431HI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","GPCR","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657573046","title":"Structure Therapeutics Inc. Q2 Net Income USD -106.159 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657573046","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657573046?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:05","pubTimestamp":1786046712,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXXNQV5G:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4599","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657661494","title":"Structure Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2657661494","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657661494?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:05","pubTimestamp":1786046700,"startTime":"0","endTime":"0","summary":"First patients dosed in aleniglipron (oral small molecule GLP-1 receptor agonist)Phase 3 ACCOMPLISH program for chronic weight management Data from Phase 1 SAD clinical trial of ACCG-2671 (oral small ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/06/3340722/0/en/Structure-Therapeutics-Reports-Second-Quarter-2026-Financial-Results-and-Recent-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JDOC","BK4007","BMED","LU0823414551.USD","MEDX","LU2357125470.USD","NVIB","CCO","BK4139","GDOC","LU2506951792.HKD","IDNA","LU2249611893.SGD","LU2294711713.HKD","LU0823414478.USD","BK4539","HYLG","BK4009","LENZ","BK4599","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656374662","title":"Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=2656374662","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656374662?lang=en_us&edition=fundamental","pubTime":"2026-08-03 21:24","pubTimestamp":1785763440,"startTime":"0","endTime":"0","summary":"WILMINGTON, Del., Aug.  03, 2026  (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR) (“Exicure” or the “Company”) today announced that it expects to issue 172,058 shares of its common stock to GPCR Ther","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/03/3337599/33289/en/Exicure-to-Settle-GPCR-Therapeutics-Clinical-Milestone-Payment-Through-Equity-Issuance.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","REZ","GPCR","BK4215","BK4007","EQR","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651491162","title":"Structure Therapeutics CSO Lin Xichen Disposes of USD 401,255.43 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2651491162","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651491162?lang=en_us&edition=fundamental","pubTime":"2026-07-16 06:58","pubTimestamp":1784156312,"startTime":"0","endTime":"0","summary":"Structure Therapeutics CSO Lin Xichen disposes of USD 401,255.43 in common sharesStructure Therapeutics Chief Scientific Officer Lin Xichen cut direct ordinary share holdings to 228,960 on July 14.Lin","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL3jwSsc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Structure Therapeutics CSO Lin Xichen Disposes of USD 401,255.43 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4599","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649402939","title":"Race to Launch Weight-loss Pills Heats up as Smaller Players Advance","url":"https://stock-news.laohu8.com/highlight/detail?id=2649402939","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649402939?lang=en_us&edition=fundamental","pubTime":"2026-07-08 00:12","pubTimestamp":1783440755,"startTime":"0","endTime":"0","summary":"FACTBOX-Race to launch weight-loss pills heats up as smaller players advanceAdds details of Kailera Therapeutics' obesity drug in paragraphs 1,2 and 25July 7 (Reuters)-Kailera Therapeutics'KLRA.Ooral ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nL4N4391DU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0964807845.USD","LU0466842654.USD","SG9999014567.USD","OZEM","LU1035773651.USD","LU0266013472.USD","LU0345770993.USD","LU0943347566.SGD","LU2089984988.USD","LU0203201768.USD","LU0882574055.USD","BK4581","LU2461242641.AUD","LU0203345920.USD","LU1923622614.USD","IE00BZ1G4Q59.USD","SGXZ57979304.SGD","IE00BFTCPJ56.SGD","LU0316494557.USD","IE0004445015.USD","LU1548497426.USD","BK1515","LU2168564495.EUR","AZNH","BK4532","LU2111349929.HKD","FTXH","BK4559","IE00BKPKM429.USD","SG9999015945.SGD","LU1116320901.HKD","LU1814569148.SGD","LU2602419157.SGD","LU0130517989.USD","LU1629891620.HKD","BK1574","LLYZ","LU2265009873.SGD","THNR","VHT","IE00BFSS7M15.SGD","CANC","LU0417517546.SGD","SG9999014906.USD","IE00B4R5TH58.HKD","LU2242644610.SGD","LU2125909593.SGD","LU2360032135.SGD","LU0965509101.SGD","LU0980610538.SGD","LU2756315318.SGD","SGXZ31699556.SGD","HK0000165453.HKD","LU0823434583.USD","LLYX","LU2471134879.HKD","LU0985320562.USD","SG9999014575.USD","LU0320765992.SGD","LU2324357040.USD","ELIL","LU1127390331.HKD","BK4534","LU0823434740.USD","GB00BDT5M118.USD","LU0354030511.USD","IE00B1BXHZ80.USD","IE00BWXC8680.SGD","IE00B3T34201.USD","LU1066051811.HKD","IE0001KFT4U8.USD","BK1161","LU0820561909.HKD","LU0130102774.USD","LU0868494708.USD","LU0861579265.USD","JDOC","LU1868836757.USD","LU0256863811.USD","BK1583","IE00BKDWB100.SGD","LU1035775433.USD","LU2462157665.USD","LU0098860793.USD","LU2237443978.SGD","LU2112291526.USD","LU0320765059.SGD","LU0058720904.USD","LU1829250122.USD","IE00BK4W5L77.USD","LU2896262040.SGD","SG9999013999.USD","LU2028103732.USD","01801","LU2168564149.EUR","LU2596442595.SGD","IE00BK4W5M84.HKD","SG9999003800.SGD","LU2328871848.SGD","LU2746668974.SGD","LU0868494617.USD","LU2357627491.SGD","LU2552382132.HKD","LU0385154629.USD","LU0070302665.USD","IE00BN8TJ469.HKD","LU2087625088.SGD","IE00BJLML261.HKD","LU1232071149.USD","LU2433249047.HKD","LU2023250504.SGD","LU2097828631.EUR","ILDR","LU0965509010.AUD","LU1989771016.USD","LU1868837300.USD","LU2237443622.USD","BK4592","IE00BJT1NW94.SGD","LU0158827948.USD","LU1712237335.SGD","LU2213496289.HKD","LU2491050154.USD","LU1983299246.USD","LU1941712264.USD","LU1720051017.SGD","ELIS","GDOC","LU0320765489.SGD","WDNA","LU1868837136.USD","BMED","LU0345770308.USD","SG9999015952.SGD","LU0128525929.USD","LU0456855351.SGD","LU0133085943.USD","LU0154236417.USD","LU1989772923.USD","LU1280957306.USD","MEDI","IE00BN29S564.USD","LU2023251221.USD","LU1430594728.SGD","HRTS","LU1988902786.USD","GPCR","LU2750360641.GBP","LU1929549753.HKD","LU0114720955.EUR","LU0289739699.SGD","PFE","BK4568","LU1894683348.USD","LU0265550946.USD","SG9999001440.SGD","LU1941712348.USD","SG9999017495.SGD","SG9999002224.SGD","BK4516","LU0859254822.USD","LU1720051108.HKD","BK1589","LU2488822045.USD","LU0942090050.USD","LU2125154778.USD","LU2360106947.USD","LU0477156953.USD","LU0353189680.USD","LU1804176565.USD","LU0708994859.HKD","LU0170899867.USD","LU1066051225.USD","IE00BBT3K403.USD","IE0009355771.USD","LU2417539215.USD","LU1066053197.SGD","LU2237443895.HKD","LU0203347892.USD","LU0455707207.USD","LU2468319806.SGD","LU0672654240.SGD","LU0106261372.USD","LU1551013425.SGD","LU1551013342.USD","SG9999014559.SGD","LU0122379950.USD","LU1934455863.HKD","SG9999015986.USD","LLII","LU2271345857.HKD","01672","IYH","CURE","LU0965508806.USD","LU1069347547.HKD","LU0208291251.USD","LU1291159041.SGD","LU0820561818.USD","LU1066051498.USD","LU0708995401.HKD","LU2125154935.USD","LU2361044865.SGD","LU1037948897.HKD","NVOX","LU1366192091.USD","SG9999015341.SGD","LU1699723380.USD","LU2471134952.CNY","AZN","SGXZ81514606.USD","LU2456880835.USD","SG9999001176.SGD","SG9999018857.SGD","LU0310800379.SGD","LU1145028129.USD","LU1267930730.SGD","LU2089284900.SGD","LU0234572021.USD","LU2491049909.HKD","LU1267930573.SGD","PAWZ","LU0648001328.SGD","LU1868836591.USD","IE00BFSS8Q28.SGD","LU2023250843.SGD","LU1093756325.SGD","RXL","LU2264538146.SGD","LU0320765646.SGD","LU1883839398.USD","LU2357305700.SGD","LU0965509283.SGD","IE0002141913.USD","LU0096364046.USD","NVO","PJP","LU2237443549.SGD","LU0306807586.USD","LU0321505439.SGD","IE00BLSP4239.USD","IE00B7KXQ091.USD","BK4550","LU0354030438.USD","IXJ","LU2746668461.USD","BK4533","LU0211331839.USD","SG9999014880.SGD","SG9999018865.SGD","LU0094547139.USD","LU0256863902.USD","LU1969619763.USD","LU1037948541.HKD","LLY","LU0323591593.USD","IE00BJJMRZ35.SGD","LU0471298694.HKD","AGNG","LU0158827781.USD","IE00B775H168.HKD","LU0061475181.USD","SG9999014542.SGD","LU0471298777.SGD","LU2108987350.USD","BK4007","BK4585","LU1061106388.HKD","LU1868836914.USD","LU1323610961.USD","LU0502904849.HKD","FHLC","BK4599","LU2089283258.USD","LU0432979614.USD","LU0306806265.USD","LU2211815571.USD","LU0640476718.USD","LU2097828557.USD","MRK","LU0889565916.HKD","LU2097828474.EUR","LU0321505868.SGD","LU2168564065.EUR","LU2491050071.SGD","LU0265550359.USD","LU1934455194.USD","LU2106854487.HKD","LU2237438978.USD","LU2168563687.JPY","PPH","SG9999011175.SGD","LU0006306889.USD","LU1162221912.USD","LU2750360997.AUD","LU0203202063.USD","IHE","LU1623119135.USD","LU0238689110.USD","IE00B1XK9C88.USD","LU0210536198.USD","LU1201861249.SGD","LU1974910355.USD","SG9999015978.USD","SGXZ99366536.SGD","LU0683600562.USD","LU0823416689.USD","LU1023059063.AUD","LU0820562030.AUD","SG9999014914.USD","LU2023250330.USD","MEDX","NVOH","LU2361044949.HKD","LU1585245621.USD","IE0004445239.USD","LU2756315664.SGD","BK4139","LU2361045086.USD","LU0225283273.USD","KLRA","LU2471134523.USD","LU0787776722.HKD","LU0097036916.USD","LU1057294990.SGD","SGXZ51526630.SGD","LU0109394709.USD","LU2168564222.USD","LU2236285917.USD","IE00B2B36J28.USD","LU2097828805.USD","IE0002270589.USD","LU0225284248.USD","LU0225771236.USD","LU0689472784.USD","LU1064131342.USD","LU1069344957.HKD","LU1116320737.USD","LU0109391861.USD","LU2552382058.USD","XLV","LU0079474960.USD","LU2125909247.SGD","BK4588","LU2237443382.USD","LU1934455277.USD","SG9999015358.SGD","LU1989772840.SGD","LU0985481810.HKD","SG9999002232.USD","SG9999001176.USD","VKTX","LU1093756168.USD","LU0029864427.USD","LU2097828714.EUR","LU0353189763.USD","LU2552382215.SGD","LU2471134796.USD","IE0005OL40V9.USD","IE00B19Z3581.USD","LU0882574139.USD","LU2237443465.HKD","IE000M9KFDE8.USD","KURE","IE00BSNM7G36.USD","LU1571399168.USD","LU1917777945.USD","LU0786609619.USD","IE00B19Z3B42.SGD","IE00BJJMRX11.SGD","IE00BLSP4452.SGD","LU0198837287.USD","IE00BKVL7J92.USD","IE00BJJMRY28.SGD","IE00B4JS1V06.HKD","LU1894683264.USD","LU2063271972.USD","SG9999014898.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111335248","title":"Trump’s FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?","url":"https://stock-news.laohu8.com/highlight/detail?id=1111335248","media":"Macro World","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111335248?lang=en_us&edition=fundamental","pubTime":"2026-07-06 11:39","pubTimestamp":1783309194,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"37c8d9de4cc74b718092c554f88a5cc4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOX","PFE","LLYX","NVOH","RHHBY","LLII","VKTX","ELIS","AMGN","LLY","ELIL","NVO","LLYZ","GPCR"],"isVideo":true,"video":{"duration":74,"video_url":"https://1254107296.vod2.myqcloud.com/e2ad4227vodcq1254107296/9044a4515001834810501024972/MWrOTca1gokA.mp4","video_thumbnail":"https://community-static.tradeup.com/news/42e81e07ef6b910080850b2d9b343c60","audio_url":"","isAI":true},"gpt_icon":0},{"id":"2644672036","title":"Structure Therapeutics shareholders elect directors at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2644672036","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644672036?lang=en_us&edition=fundamental","pubTime":"2026-06-19 04:06","pubTimestamp":1781813185,"startTime":"0","endTime":"0","summary":"Structure Therapeutics held its annual shareholder meeting on June 17, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Structure Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL8tXw4y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","GPCR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643788133","title":"Why Structure Therapeutics (GPCR) Is Up 13.7% After Phase 2b Obesity Data Hit Nature Medicine And ADA","url":"https://stock-news.laohu8.com/highlight/detail?id=2643788133","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643788133?lang=en_us&edition=fundamental","pubTime":"2026-06-16 01:16","pubTimestamp":1781543787,"startTime":"0","endTime":"0","summary":"Structure Therapeutics announced that Phase 2b ACCESS trial results for its oral GLP-1 receptor agonist aleniglipron in people with overweight or obesity were published in Nature Medicine and presented at the American Diabetes Association’s 86th Scientific Sessions, showing statistically significant efficacy across three maintenance doses and a safety profile consistent with the GLP-1 class.\nThe interim open-label extension data, indicating durable weight loss beyond 36 weeks and improved...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gpcr/structure-therapeutics/news/why-structure-therapeutics-gpcr-is-up-137-after-phase-2b-obe","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gpcr/structure-therapeutics/news/why-structure-therapeutics-gpcr-is-up-137-after-phase-2b-obe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4599","GPCR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643524302","title":"XtalPi Biopharma GPCR Pact Tests AI Drug Discovery And Revenue Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2643524302","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643524302?lang=en_us&edition=fundamental","pubTime":"2026-06-14 09:21","pubTimestamp":1781400115,"startTime":"0","endTime":"0","summary":"XtalPi Holdings (SEHK:2228) has entered a new partnership with a major international biopharma company to develop oral small molecule drugs targeting a complex GPCR.\nThe collaboration uses XtalPi's AI and quantum physics platforms, combined with automated labs, to work on challenging GPCR targets.\nThe deal carries a potential value of more than US$400 million, reflecting meaningful commercial scope for XtalPi's technology.\n\nXtalPi Holdings trades at HK$7.04, with the share price down 6.0%...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2228/xtalpi-holdings-shares/news/xtalpi-biopharma-gpcr-pact-tests-ai-drug-discovery-and-reven","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2228/xtalpi-holdings-shares/news/xtalpi-biopharma-gpcr-pact-tests-ai-drug-discovery-and-reven","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AGIX","GPCR","ARTY","CHAT","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642443650","title":"Nxera Pharma Joins OpenFold AI Consortium to Boost GPCR Drug Discovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2642443650","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642443650?lang=en_us&edition=fundamental","pubTime":"2026-06-10 14:58","pubTimestamp":1781074702,"startTime":"0","endTime":"0","summary":"Sosei Group ( ($JP:4565) ) just unveiled an update. Nxera Pharma, a biopharma specialist in GPCR structure-based drug discovery, has built a Japan-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nxera-pharma-joins-openfold-ai-consortium-to-boost-gpcr-drug-discovery?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nxera-pharma-joins-openfold-ai-consortium-to-boost-gpcr-drug-discovery?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","BK4007","AIPO","GPCR","CHAT","AGIX","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642951064","title":"XtalPi Strikes US$400 Million GPCR Drug Discovery Pact with Global Biopharma Partner","url":"https://stock-news.laohu8.com/highlight/detail?id=2642951064","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642951064?lang=en_us&edition=fundamental","pubTime":"2026-06-09 22:41","pubTimestamp":1781016113,"startTime":"0","endTime":"0","summary":"QuantumPharm, Inc. ( ($HK:2228) ) has provided an update. XtalPi Holdings Limited has entered a strategic partnership with a leading international ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/xtalpi-strikes-us400-million-gpcr-drug-discovery-pact-with-global-biopharma-partner?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/xtalpi-strikes-us400-million-gpcr-drug-discovery-pact-with-global-biopharma-partner?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","GPCR","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117976358","title":"XTALPI Forges Strategic AI Drug Discovery Alliance Valued Over $400M with Global Pharma Leader for Oral GPCR Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1117976358","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117976358?lang=en_us&edition=fundamental","pubTime":"2026-06-09 22:40","pubTimestamp":1781016053,"startTime":"0","endTime":"0","summary":"XTALPI (ASX: 02228) has announced a significant strategic collaboration with a prominent international biopharmaceutical company. The partnership is centered on the joint development of a novel oral...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","AIPO","BK1617","BK4599","ARTY","GPCR","02228","BK4007","AGIX","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641485838","title":"Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2641485838","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641485838?lang=en_us&edition=fundamental","pubTime":"2026-06-08 18:20","pubTimestamp":1780914051,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS) and Structure Therapeutics, Inc. Spo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-and-structure-therapeutics-inc-sponsored-adr-gpcr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-and-structure-therapeutics-inc-sponsored-adr-gpcr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","GPCR","LU0128526141.USD","BK4137","LU0029874061.USD","LABU","BK4581","XBI","HCSG","XLV","BK4588","BK4139","BK4585","ALKS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641483261","title":"How Phase 2b Oral GLP-1 Data and Phase 3 Plans Will Impact Structure Therapeutics (GPCR) Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2641483261","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641483261?lang=en_us&edition=fundamental","pubTime":"2026-06-08 16:14","pubTimestamp":1780906459,"startTime":"0","endTime":"0","summary":"Structure Therapeutics recently published Phase 2b ACCESS trial results for its oral GLP-1 agonist aleniglipron in Nature Medicine and presented the data at the American Diabetes Association’s 86th Scientific Sessions, showing statistically significant weight loss and improvements in multiple cardiovascular risk markers in people with obesity or overweight.\nAn interesting insight from the open-label extension is that many participants who interrupted dosing could restart or up-titrate...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gpcr/structure-therapeutics/news/how-phase-2b-oral-glp-1-data-and-phase-3-plans-will-impact-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gpcr/structure-therapeutics/news/how-phase-2b-oral-glp-1-data-and-phase-3-plans-will-impact-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4590","GLP","BK4599","BK4007","GPCR","ISBC","BK4144","BK4211"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":79,"code":"91000000","status":"200"}]}}